SHS acquires a stake in Betterguards Technology
Tübingen/Berlin, May 14, 2019 — With its fifth fund, the Tübingen-based medical technology investor SHS Gesellschaft für Beteiligungsmanagement mbH is investing a mid-single-digit million amount in Betterguards Technology GmbH. The technology of the Berlin-Brandenburg company is aimed primarily at manufacturers in the sports equipment, orthopedic technology and occupational safety sectors. Based on an innovative combination of materials, Betterguards has developed a platform technology that protects human joints, preventing ligament and tendon injuries in particular. In addition to SHS, previous investors BFB Brandenburg Kapital, a subsidiary of Brandenburg’s development bank ILB, and Die BrückenKöpfe also participated in the financing round. For SHS, it is the third investment from the fifth fund. The fund will be used to build a diversified portfolio of medical technology and life science companies. Final closing of the fund is expected shortly.
Betterguards Technology GmbH, founded in 2014 and based in Berlin with a production facility in Brandenburg, develops and produces intelligent components (so-called adaptors) that can be integrated, for example, into sports shoes, bandages or protective work shoes. Equipped with this unique selling point, wearers can be protected from joint injuries. Betterguards is already working with Juzo, a provider of sports medical bandages and orthotics.
The underlying, broadly patented technology combines freedom of movement and protection: Betterguards’ Adaptor, which stretches during normal movements, stiffens within a very short time only during very fast, critical movements — such as when twisting an ankle — and thus protects the joint from overextension; afterwards, immediately after the critical force has passed, it returns to its stretchable initial state and allows a natural movement pattern.
“We are very pleased to have another specialist in the medical technology and healthcare market on board with SHS. SHS’ industry expertise and know-how will further help us to position our company even better in the healthcare market and to fully exploit the growth potential of our platform technology,” says Vinzenz Bichler, founder and CEO of Betterguards.
Cornelius Maas, Senior Investment Manager at SHS, comments: “What impressed us about Betterguards was the combination of new-materials and engineering expertise. For ankle protection, the company has already entered into a strategic partnership with a renowned orthopedic technology manufacturer. We are convinced that we have identified a high-growth company in Betterguards, which we are happy to support in its further development steps. We are very much looking forward to the cooperation.”
“With Betterguards, our team was able to realize the third transaction for our SHS V fund from our strong deal pipeline. Investors looking for a private equity investment in the high-growth medical technology and life science market can still participate in the sector fund for a few more weeks,” says Hubertus Leonhardt, Managing Director and Partner at SHS
About SHS Gesellschaft für Beteiligungsmanagement mbH
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement invests in medical technology and life science companies with a focus on expansion financing, shareholder changes and succession situations. In doing so, SHS enters into both minority and majority shareholdings. As an experienced industry investor, the company, which was founded in 1993, supports the growth of its portfolio companies through a network of collaborations, for example in the introduction of new products, regulatory issues or entry into additional markets.
The German and international investors in SHS funds include professional pension funds, pension funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The equity investment of the AIFM-registered company is up to € 30 million, volumes exceeding this can be implemented with a network of co-investors. SHS is currently launching its fifth fund. The fund has already received capital commitments of more than EUR 100 million and is still open to investors until June 30, 2019. www.shs-capital.eu